Azenta, Inc. Overview
Pro stress-test →Azenta is a life sciences technology company specializing in sample management, cryogenic storage and genomic services for research and clinical applications. The company operates in the critical "cold chain" infrastructure for life sciences, managing biological samples for mRNA vaccines and cell and gene therapy applications.
Strategic Profile
Pro stress-test →The company is a pure-play life sciences firm attempting to prove its "Sample-to-Insight" strategy can yield consistent profits. Azenta is streamlining its portfolio through a definitive agreement to sell B Medical Systems for $63 million and authorized a $250 million share repurchase program through 2028.
Competitive Landscape
Pro stress-test →Azenta competes in life sciences sample management and genomic services against specialized lab automation providers and biorepository network operators. The company trades near its book value when accounting for cash, but repeated earnings misses have created a "show-me" story. The sector is challenged by sluggish biotech spending recovery and execution risks in scaling automated infrastructure.
Industry Context
Azenta, Inc. operates in Life Sciences Technology & Services.
Key facts
Headquarters: Burlington, US · Revenue: $594M (FY2025) · Market cap: $1.24B